CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Open-market buy Vice Chairman & COO bought 1,500 shares at an average $1.32 ($1,980)
- 4 Open-market buy Chairman and CEO bought 4,900 shares at $1.48 ($7,252)
- 4 Open-market buy Vice Chairman & COO bought 6,550 shares at an average $1.59 ($10,432)
- 4 Open-market buy Chairman and CEO bought 7,200 shares at an average $1.54 ($11,097)
- 4 Open-market buy Chairman and CEO bought 11,600 shares at an average $1.60 ($18,571)
- 4 Open-market buy Vice Chairman & COO bought 2,500 shares at an average $1.68 ($4,204)
- 4 Open-market buy Chairman and CEO bought 42,850 shares at an average $1.44 ($61,896)
- 4 Open-market buy Vice Chairman & COO bought 11,150 shares at an average $1.37 ($15,312)
- 4 Open-market buy Chairman and CEO bought 23,750 shares at an average $1.67 ($39,734)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 8-K Event Material agreement · New debt or obligation
- 4 Open-market buy Chairman and CEO bought 48,000 shares at an average $1.80 ($86,580)
- 4 Open-market buy Chairman and CEO bought 22,750 shares at an average $1.82 ($41,315)
- 4 Open-market buy Vice Chairman & COO bought 3,000 shares at an average $1.77 ($5,305)
- 4 Open-market buy Chairman and CEO bought 31,100 shares at an average $1.80 ($56,116)
- 4 Open-market buy Chairman and CEO bought 18,800 shares at an average $1.28 ($23,998)
- 4 Open-market buy Vice Chairman & COO bought 4,550 shares at an average $1.31 ($5,961)
- 8-K Event Auditor change
- 8-K Event Material agreement
Page 15 of 63 · 1,250 filings